Latest News

University of California, Irvine (UCI) researchers, led by BrightFocus researcher Frank M. LaFerla, PhD, have published positive findings from mice studies that suggest cell therapy slows down brain changes and symptoms linked to Alzheimer’s disease.

Download the fall 2013 issue of our glaucoma newsletter to learn about an FDA-approved glaucoma drug called Simbrinza™ Suspension, strategies for everyday life with glaucoma, and much more.

Download the winter 2014 issue of our glaucoma newsletter to learn about a recently discovered common genetic marker for elevated intraocular pressure, risks associated with certain glaucoma drugs, and much more.

Download the summer 2014 issue of our glaucoma newsletter to learn about a set of molecules that could block myocilin accumulation, drug-delivering contact lenses for glaucoma patients, and much more.

Download the fall 2014 issue of our glaucoma newsletter to learn about injections that could replace daily eye drops for glaucoma, the visual field test, and much more.

Download the fall 2013 issue of our macular degeneration newsletter to learn more about the importance of early diagnosis in managing AMD, innovative visual aids for AMD patients, and much more.

A large clinical trial aimed at screening and early treatment for Alzheimer’s disease holds the potential to be groundbreaking—if enough volunteers can be recruited to get it off the ground.

Download the spring 2014 issue of our macular degeneration newsletter to learn about a potential topical treatment for AMD, how to choose sunglasses that will protect against AMD, and much more.

Download the summer 2014 issue of our macular degeneration newsletter to learn about new treatments that could eventually replace eye injections for AMD, low vision tips, and much more.